Cart

YOUR CART IS EMPTY

Add research compounds to begin your order.

Peer-reviewed human trials and related publicationsSee approved evidence mapCompleted

Lancet Diabetes & Endocrinology

RET-STUDY-P007

Coskun T, et al. Retatrutide body-composition substudy. Lancet Diabetes & Endocrinology. 2025. DOI: 10.1016/S2213-8587(25)00092-0. PMID: 40609566. https://pubmed.ncbi.nlm.nih.gov/40609566/

Study design

Record details

Design: Peer-reviewed human trials and related publications

Evidence record

Endpoints, findings, and limitations

Limitations

This study record is an evidence-index entry. Interpret the design, material, population or model, endpoints, findings, and limitations only within the linked approved source and compound evidence map; do not transfer outcomes across compounds, materials, cohorts, or models.

Reports and sources

Reference ledger

P007Peer-reviewed human trials and related publications

Lancet Diabetes & Endocrinology

Coskun T, et al. Retatrutide body-composition substudy. Coskun T, et al. Retatrutide body-composition substudy. Lancet Diabetes & Endocrinology. 2025. DOI: 10.1016/S2213-8587(25)00092-0. PMID: 40609566. https://pubmed.ncbi.nlm.nih.gov/40609566/(2025). DOI: 10.1016/S2213-8587(25